Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 5 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 3 days agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 3 days agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
Johnson & Johnson (NYSE:JNJ) is Adirondack Trust Co.’s 10th Largest Position
ETF DAILY NEWS· 4 days agoAdirondack Trust Co. cut its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 5 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks· 2 days agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's disease. This marks the second sBLA filing for Tremfya in three months.
Johnson & Johnson (NYSE:JNJ) Position Lifted by Cox Capital Mgt LLC
ETF DAILY NEWS· 1 day agoCox Capital Mgt LLC grew its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional ...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis
MedPage Today· 5 days agoPrevious exposure to biologics, higher BMI, smoking all negatively linked to response